Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Surya Ayalasomayajula is working as Senior Investigator II at Novartis Pharamceuticals Co.USA. Lead PK group efforts in submitting IND and NDA applications. Contributed to ClinPharm summary, Clin biopharm summary, Clin Overview, CSE, CSS, RMP, Company core data sheet, Prescription information and other key NDA documents. Plan, design, analyze, interpret, and report data from clinical pharmacokinetics (PK) and PK/Pharmacodynamic (PD) studies Responsible for the PK, and PK/PD components of the stud protocols, reports, and drug development plans. Serve as the key contact for all PK, and PK/PD related issues pertinent to the development of drug candidate. Interact with multiple line functions to ensure preclinical and clinical pharmacokinetic/pharmacodynamic information is used optimally for the early and late phase clinical development plans.
Pharmacokinetics, DMPK, Drug Metabolism, Bioanalysis, Clinical Development, Drug Development, HPLC, Clinical Pharmacology, PK/PD, Biopharmaceuticals
Research Article: Clin Pharmacol Biopharm 2015, 4:147
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals